Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

AlyveRx vs No BS RX

By GLP-1 ScorecardUpdated

AlyveRxFactor scores not reassessed.
Site position #115

Lower score

No BS RXFactor scores not reassessed.
Site position #23

Higher score

Score comparison

No BS RX has the higher recorded score — 82.8/100 to 70.5/100.

No BS RX grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. No BS RX publishes separate prices for standard compounded, low-dose and brand-name programs.

Before you choose

Before comparing the headline prices, the AlyveRx review and the No BS RX review set out the plan length, renewal date and extra fees behind each semaglutide figure in the table below, and the semaglutide cost page compares published rates across the field. A lower starting price can still mean a larger bill once a longer commitment or a separate membership is added.

If neither one fits, AlyveRx vs OnlyRx and Amazon One Medical vs No BS RX compare each of them with another graded program, and the list of alternatives to AlyveRx ranks the programs closest to AlyveRx on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.

Of the sellers that pay us a commission, the Direct Meds review covers one graded close to these two, at 77.6/100. That relationship never changes a grade, and the review lists what we could not verify.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valueNo BS RX +23
69
92
Dose & formulationAlyveRx +6
96
90
Clinical oversightNo BS RX +1
71
72
Labs & monitoringNo BS RX +16
52
68
FulfillmentNo BS RX +30
64
94
Contract termsNo BS RX +19
55
74
AlyveRx · top barNo BS RX · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricAlyveRxNo BS RX
WeighScore70.5/10082.8/100
GradeCB−
Site position#115#23
SemaglutideFrom $183/mo injection or $203/mo drops; confirm dose and renewal$149/mo advertised for standard compounded injection; low-dose priced separately
TirzepatideFrom $283/mo injection or $249/mo drops; confirm dose and renewal$225/mo advertised for standard compounded injection; low-dose priced separately
CoverageCoverage not publishedConfirm program availability for your state
Brand-name accessYesYes
Oral / sublingualYesYes
AlyveRx

Site position #115 · C

Factor scores not reassessed.

Strengths

  • Lists separate starting prices for injections and drops
  • Separately lists Ozempic, Wegovy and Mounjaro

What to consider

  • Starting prices do not establish the charge at every dose
  • Public terms allow automatic renewal on certain plans
  • Dispensing pharmacy and state availability not confirmed
No BS RX

Site position #23 · B−

Factor scores not reassessed.

Strengths

  • Displays monthly and prepaid amounts by program
  • Advertises consultation, medication, shipping and messaging in the compounded plans
  • Lists branded Ozempic and Zepbound separately

What to consider

  • The $115 headline applies to low-dose programs
  • Plans renew automatically at the then-current rate
  • Cancellation generally stops future billing without refunding the current period

Featured provider

CoreAge Rx

CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.

Commercial relationships affect this placement. The score comparison above is separate.

Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.

← Back to the scorecard